Top compounds associated with response to RP11-526A4.1


Feature Type Standardized
Nominal ANOVA
mRNA Oxaliplatin CTRPv2 pan-cancer AAC 0.0071 0.8
mRNA BRD-K79669418 CTRPv2 pan-cancer AAC 0.011 0.8
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.0062 0.8
mRNA BRD-K51831558 CTRPv2 pan-cancer AAC 0.011 0.8
mRNA semagacestat CTRPv2 pan-cancer AAC 0.0077 0.8
mRNA AZD0530 CCLE pan-cancer AAC 0.0095 0.8
mRNA BRD-K02251932 CTRPv2 pan-cancer AAC 0.0078 0.8
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.0073 0.8
mRNA Vandetanib CCLE pan-cancer AAC 0.0092 0.8
mRNA B02 CTRPv2 pan-cancer AAC -0.0071 0.8
Download CSV